| Literature DB >> 33751548 |
Paul Deschamps1,2, Mufaddal Moonim1,3, Deepti Radia1, Natalia Curto-Garcia1, Claire Woodley1, Sarah Bassiony1, Jennifer O'Sullivan1, Patrick Harrington1, Kavita Raj1, Yvonne Francis1, Shahram Kordasti1,4, Sahra Ali1, Claire N Harrison1, Donal P McLornan1.
Abstract
Myeloproliferative neoplasm-unclassifiable (MPN-U) presents an MPN-type phenotype that fails to meet diagnostic criteria for other MPN variants. Variability in the clinicopathological phenotypes presents many challenges. Amongst a registry cohort of 1512 patients with MPN, 82 with MPN-U were included, with a median (range) age of 49·7 (13-79) years. Albeit heterogeneous, common presentation features included raised lactate dehydrogenase, thrombocytosis and clustered/pleomorphic megakaryocytes on trephine biopsy. Thrombosis was common (21%), necessitating vigilance. The median event-free survival was 11·25 years (95% confidence interval 9·3-not reached), significantly shortened in cases with lower platelet counts (<500 × 109 /l) and a leucocytosis (≥12 × 109 /l) at presentation. Generation of potential MPN-U prognostic scores is required.Entities:
Keywords: clinical data; genomics; myeloproliferative neoplasms-unclassifiable; outcome
Year: 2021 PMID: 33751548 DOI: 10.1111/bjh.17375
Source DB: PubMed Journal: Br J Haematol ISSN: 0007-1048 Impact factor: 6.998